CIENCIASMEDICASNEWS: D614G : SARS-CoV-2 S1 Variant

lunes, 8 de junio de 2020

D614G : SARS-CoV-2 S1 Variant

	Drug Discovery and Production
	The latest drug discovery news from News Medical

Monitoring Ambient Environmental Conditions in the Lab

D614G: SARS-CoV-2 S1 Variant

D614G mutation enables SARS-CoV-2 to be more transmissive. Sino Biological developed a recombinant S1 D614G and other mutations to help learning the biology of those variants.

Find Out More

How Automation is Benefiting Gene Editing

CRISPR-based gene editing has been a cornerstone technology for both commercial and academic genetics labs since its ability to modify genetic code accurately and permanently was first described under a decade ago. It is a technology with tremendous potential to affect the whole scientific spectrum, from drug discovery through to direct therapeutic applications.

Imaging Techniques in Drug Discovery

Throughout the many stages of drug discovery, various imaging techniques play an important role in identifying drug targets and testing candidate efficacy.

	AIs Involvement in Improving Drug Discovery The process of discovering new drugs is often long and complex. This article looks at AIs involvement in improving drug discovery.

	How could Stem Cells be Used in Drug Discovery? This article looks at how stem cells can be used in drug discovery and also how they can be used to help model various diseases.

	Innovative tool to speed up the drug discovery process A better understanding of the interaction between a molecule and the organism is important to consider its therapeutic potential.

	Project Expands Use Of Metal Catalysts For Drug Discovery The use of metals in drug delivery could offer major benefits, including allowing for lower dosages of a medication to achieve therapeutic effects.